- Home
- NIO vs ELAN Comparison
NIO vs ELAN Comparison
Compare NIO & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NIO | ELAN |
|---|---|---|
| Founded | 2014 | 1954 |
| Country | China | United States |
| Employees | 45635 | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8B | 12.7B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | NIO | ELAN |
|---|---|---|
| Price | $6.21 | $22.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | $6.73 | ★ $27.89 |
| AVG Volume (30 Days) | ★ 32.8M | 3.9M |
| Earning Date | 06-02-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $52.58 | $8.21 |
| Revenue Next Year | $18.91 | $5.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $3.35 | $9.32 |
| 52 Week High | $8.02 | $27.72 |
Technical Indicators
Market Signals| Indicator | NIO | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 51.17 | 43.34 |
| Support Level | $5.92 | $22.17 |
| Resistance Level | $6.92 | $23.16 |
| Average True Range (ATR) | 0.26 | 0.83 |
| MACD | -0.06 | -0.07 |
| Stochastic Oscillator | 21.50 | 34.52 |
Price Performance
Historical ComparisonAbout NIO NIO Inc. American depositary shares each representing one ordinary share
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 326,000 EVs in 2025, accounting for about 2% of the China passenger new energy vehicle market.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.